Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy

Blood

Volumn 89, Issue 12, 1997, Pages 4531-4536

  Giralt, Sergio ^a,b   Estey, Elihu ^a   Albitar, Maher ^a   Van Besien, Koen ^a   Rondón, Gabriela ^a   Anderlini, Paolo ^a   O'Brien, Susan ^a   Khouri, Issa ^a   Gajewski, James ^a   Mehra, Rakesh ^a   Claxton, David ^a   Andersson, Borje ^a   Beran, Miloslav ^a   Przepiorka, Donna ^a   Koller, Charles ^a   Kornblau, Steve ^a   Körbling, Martin ^a   Keating, Michael ^a   Kantarjian, Hagop ^a   Champlin, Richard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOGRAFT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; PRIORITY JOURNAL; PURINE METABOLISM; REMISSION; STEM CELL; THROMBOCYTE COUNT;

EID: 0030925301     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4531     Document Type: Article

References (31)

1. Bortin M, Horowitz M, Rimm A: Increasing utilization of allogeneic bone marrow transplantation: Results of the 1988-1990 survey. Ann Intern Med 116:505, 1992
2. Bortin M, Horowitz M, Gale R, Barrett J, Champlin R, Dicke K, Gluckman E, Kolb H, Marmont A, Mrsic M, Sobocinski K, Weiner R, Rimm A: Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980's. JAMA 268:607, 1992
3. Clift R, Appelbaum F, Thomas E, Bone marrow transplantation for chronic myelogenous leukemia. Blood 83:2752, 1994
4. Klingemann HG, Storb R, Fefer A, Deeg HJ, Appelbaum F, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM, Witherspoon RP, Thomas ED: Bone marrow transplantation in patients aged 45 years and older. Blood 65:770, 1986
5. Blume KG, Forman SJ, Nademanee AP, O'Donnell MR, Snyder DS, Fahey JL, Findley DO, Lipsett JA, Zaia JA, Metter GE, Hill LR: Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older. J Clin Oncol 4:1489, 1986
6. Ringden O, Horowitz MH, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM: Outcome after allogeneic bone marrow transplant for leukemia in older patients. JAMA 270:57, 1993
7. Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA, for the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologische Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups: Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: An analysis of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 17:993, 1996
8. Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet-Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E: Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 18:111, 1996
9. Sullivan K, Weiden P, Storb R, Witherspoon R, Fefer A, Fisher L, Buckner C, Anasetti C, Appelbaum F, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheeves M, Clift R, Deeg H, Doney K, Greenberg P, Hansen J, Hill R, Longhran T, Martin P, Neiman P, Peterson F, Sanders J, Singer J, Stewart P, Thomas E: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
10. Weiden P, Flournoy N, Thomas E, Prentice R, Fefer A, Buckner C, Storb R: Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300:1068, 1979
11. Weiden P, Sullivan K, Flournoy N, Storb R, Thomas E: Antileukemic effect of chronic graft-versus-host disease: Contributions to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529, 1981
12. Horowitz M, Gale R, Sondel M, Goldman J, Kersey J, Kolb H, Rimm A, Ringden O, Rozman C, Speck B, Truitt R, Zwaan F, Bortin M: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
13. Goldman J, Gale R, Horowitz M, Biggs J, Champlin R, Gluckman E, Hoffmann R, Jacobsen S, Marmont A, McGlave P, Messner H, Rimm A, Rozman C, Speck B, Weiner R, Bortin M: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion. Ann Intern Med 108:806, 1988
14. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringden O, Veum Stone JA, Bortin MM: Identicaltwin bone marrow transplants for leukemia. Ann Intern Med 120:646, 1994
15. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermuller J, de Witte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041, 1995
16. Collins R, Shpilberg O, Drobyski W, Porter D, Antin J, Wolff S, Giralt S, Chetrit A, Ognoskie N, Prine S, Nemunaitis J: Donor leukocyte infusion (DLI) for post-bone marrow transplant (BMT) relapse-retrospective cohort analysis of 141 cases. Blood 86:563a, 1995 (abstr, suppl 1)
17. Rondón G, Giralt S, Huh Y, Khouri I, Andersson B, Andreeff M, Champlin R: Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 18:669, 1996
18. Plunkett W, Sanders PP: Metabolism and action of purine nucleoside analogs. Pharmacol Ther 49:239, 1991
19. Goodman ER, Fiedor PS, Fein S, Sung RS, Athan E, Hardy MA: Fludarabine phosphate and 2-chlorodeoxyadenosine: Immunosuppressive DNA synthesis inhibitors with potential application in islet allo-xenotransplantation. Transplant Proc 27:3293, 1995
20. Gorski A, Grieb P, Korczak-Kowalska G, Wierzbicki P, Stepien-Sopniewska B, Mrowiec T: Cladribine (2-chloro-deoxyadenosine, CDA): An inhibitor of human B and T cell activation in vitro. Immunopharmacology 26:197, 1993
21. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan KW, Champlin R, Körbling M: Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 36:596, 1996
22. Estey E, Plunkett W, Gandhi V, Rios MB, Kantarjian H, Keating MJ: Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. Leuk Lymphoma 9:343, 1993
23. Kornblau S, Andreeff M, Beran M, Escudier S, Kantarjian H, Koller C, O'Brien S, Robertson LE, Estey E: 2-CDA ± Ara-C is ineffective therapy for relapsed or refractory AML in adults. Proc Am Soc Clin Oncol 14:336, 1995
24. Standing Committee on Human Cytogenetic Nomenclature: An international system for human cytogenetic nomenclature 20 (1978 ISCN). Cytogenet Cell Genet 21:309, 1978
25. Yam P, Petz L, Knowlton R, Wallace R, Stock A, DeLange G, Brown V, Doris-Keller H, Blume K: Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 43:399, 1987
26. Bearman SI, Appelbaum FR, Buckner CD, Peterscn FB, Fisher LD, Clift RA, Thomas ED: Regimen related toxicities in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562, 1988
27. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft versus host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 18:295, 1974
28. Schulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED: Chronic graft-versus-host disease syndrome in man. A long term clinical pathologic study of 20 Seattle patients. Am J Med 69:204, 1980
29. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
30. Giralt SA, Champlin RE: Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 84:3603, 1994
31. Keating M, Kantarjian H, Smith T, Estey E, Walters R, Andersson B, Beran M, McCredie K, Freireich E: Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 7:1071, 1989